Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CRO 8970 (CRO.V)	C$0.02 +50.0%	C$0.02	C$0.01 ▼ C$0.03	C$2.10M	N/A	1.53 million shs	2.78 million shs
PTX Pernix Therapeutics		$0.16	$0.20 ▼ $3.30	$419K	1.2	3.04 million shs	16,105 shs
SAN Banco Santander	$8.42 -1.1%	$8.09	$4.27 ▼ $8.90	$128.95B	0.99	4.42 million shs	4.85 million shs
TEL TE Connectivity	$179.03 +0.8%	$165.93	$116.30 ▼ $179.73	$52.69B	1.23	1.72 million shs	4.34 million shs

Analysts Agree—These Gold Picks Outshine the Rest

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CRO 8970 (CRO.V)	0.00%	0.00%	0.00%	0.00%	0.00%
PTX Pernix Therapeutics	0.00%	0.00%	0.00%	0.00%	0.00%
SAN Banco Santander	+0.71%	-0.82%	+7.45%	+26.47%	+74.82%
TEL TE Connectivity	+0.89%	+1.62%	+8.55%	+37.55%	+13.18%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CRO 8970 (CRO.V)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PTX Pernix Therapeutics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SAN Banco Santander	3.4099 of 5 stars	0.0	3.0	2.5	2.8	2.6	0.0	3.1
TEL TE Connectivity	4.5798 of 5 stars	2.4	5.0	4.2	1.0	3.3	2.5	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CRO 8970 (CRO.V)	0.00	N/A	N/A	N/A
PTX Pernix Therapeutics	0.00	N/A	N/A	N/A
SAN Banco Santander	3.00	Buy	N/A	N/A
TEL TE Connectivity	2.83	Moderate Buy	$177.10	-1.08% Downside

Current Analyst Ratings Breakdown

Latest CRO, TEL, PTX, and SAN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/17/2025	TEL TE Connectivity	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$148.00 ➝ $186.00
7/14/2025	TEL TE Connectivity	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$185.00 ➝ $201.00
7/11/2025	TEL TE Connectivity	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
7/11/2025	TEL TE Connectivity	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$150.00 ➝ $200.00
7/10/2025	TEL TE Connectivity	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$168.00 ➝ $190.00
7/1/2025	TEL TE Connectivity	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$156.00 ➝ $170.00
6/4/2025	SAN Banco Santander	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy
5/30/2025	TEL TE Connectivity	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$163.00 ➝ $185.00
5/19/2025	TEL TE Connectivity	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$148.00 ➝ $156.00
4/25/2025	TEL TE Connectivity	Vertical Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$170.00
4/24/2025	TEL TE Connectivity	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$155.00 ➝ $163.00

(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CRO 8970 (CRO.V)	N/A	N/A	N/A	N/A	N/A	N/A
PTX Pernix Therapeutics	$146.07M	0.00	N/A	N/A	($14.77) per share	0.00
SAN Banco Santander	$66.96B	1.91	$1.07 per share	7.84	$7.34 per share	1.15
TEL TE Connectivity	$15.85B	3.35	$10.49 per share	17.07	$40.65 per share	4.40

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CRO 8970 (CRO.V)	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
PTX Pernix Therapeutics	-$77.14M	N/A	0.00	N/A	N/A	-59.70%	N/A	-37.01%	N/A
SAN Banco Santander	$13.61B	$0.87	9.68	9.15	0.95	16.92%	12.26%	0.72%	7/30/2025 (Estimated)
TEL TE Connectivity	$3.19B	$4.55	39.35	20.09	2.20	8.67%	19.40%	10.45%	7/23/2025 (Estimated)

Latest CRO, TEL, PTX, and SAN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/30/2025	Q2 2025	SAN Banco Santander	$0.27	N/A	N/A	N/A	$17.69 billion	N/A
7/23/2025	Q3 2025	TEL TE Connectivity	$2.07	N/A	N/A	N/A	$4.30 billion	N/A
4/30/2025	Q1 2025	SAN Banco Santander	$0.22	$0.22	N/A	$0.22	$15.94 billion	$17.69 billion
4/23/2025	Q2 2025	TEL TE Connectivity	$1.96	$2.10	+$0.14	$0.04	$3.97 billion	$4.14 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CRO 8970 (CRO.V)	N/A	N/A	N/A	N/A	N/A
PTX Pernix Therapeutics	N/A	N/A	N/A	N/A	N/A
SAN Banco Santander	$0.18	2.14%	N/A	20.69%	N/A
TEL TE Connectivity	$2.84	1.59%	N/A	62.42%	12 Years

Latest CRO, TEL, PTX, and SAN Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/11/2025	TEL TE Connectivity	quarterly	$0.71	1.71%	8/22/2025	8/22/2025	9/12/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CRO 8970 (CRO.V)	N/A	N/A	N/A
PTX Pernix Therapeutics	N/A	1.08	0.92
SAN Banco Santander	N/A	0.25	0.25
TEL TE Connectivity	0.27	1.51	1.08

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CRO 8970 (CRO.V)	N/A
PTX Pernix Therapeutics	20.43%
SAN Banco Santander	9.19%
TEL TE Connectivity	91.43%

Insider Ownership

Company	Insider Ownership
CRO 8970 (CRO.V)	N/A
PTX Pernix Therapeutics	1.30%
SAN Banco Santander	9.48%
TEL TE Connectivity	0.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CRO 8970 (CRO.V)	147,000	140.00 million	N/A	Not Optionable
PTX Pernix Therapeutics	N/A	14.51 million	N/A	Optionable
SAN Banco Santander	199,958	15.15 billion	13.72 billion	Optionable
TEL TE Connectivity	87,000	296.55 million	293.88 million	Optionable

CRO, TEL, PTX, and SAN Headlines

Recent News About These Companies

TE Connectivity (NYSE:TEL) Price Target Raised to $186.00 at JPMorgan Chase & Co.

July 18 at 1:41 PM | marketbeat.com

TE Connectivity shares climb to record high of $179.45 amid strong earnings and upbeat outlook

July 18 at 11:27 AM | msn.com

Wealthfront Advisers LLC Has $4.53 Million Holdings in TE Connectivity Ltd. (NYSE:TEL)

July 18 at 5:55 AM | marketbeat.com

TE Connectivity Ltd. (NYSE:TEL) Stock Position Reduced by Burling Wealth Partners LLC

July 17 at 9:49 AM | marketbeat.com

TE Connectivity Ltd. (NYSE:TEL) Shares Bought by Pzena Investment Management LLC

July 17 at 9:16 AM | marketbeat.com

TE Connectivity Ltd. (NYSE:TEL) Stake Lowered by Cooke & Bieler LP

July 17 at 9:02 AM | marketbeat.com

TE Connectivity (NYSE:TEL) Hits New 1-Year High - Should You Buy?

July 16 at 6:43 AM | marketbeat.com

TE Connectivity Ltd. (NYSE:TEL) Shares Sold by Bogart Wealth LLC

July 16 at 5:39 AM | marketbeat.com

Schechter Investment Advisors LLC Takes Position in TE Connectivity Ltd. (NYSE:TEL)

July 16 at 4:33 AM | marketbeat.com

TE Connectivity (TEL) Projected to Post Quarterly Earnings on Wednesday

July 16 at 2:48 AM | marketbeat.com

5 High-ROE Stocks to Buy as Markets Soar Despite Tariff Threats

July 15 at 11:06 AM | zacks.com

Massachusetts Financial Services Co. MA Sells 82,217 Shares of TE Connectivity Ltd. (NYSE:TEL)

July 15 at 6:40 AM | marketbeat.com

TE Connectivity (NYSE:TEL) Given New $201.00 Price Target at UBS Group

July 15 at 4:04 AM | americanbankingnews.com

UBS Group Issues Positive Forecast for TE Connectivity (NYSE:TEL) Stock Price

July 14, 2025 | marketbeat.com

Wall Street Zen Upgrades TE Connectivity (NYSE:TEL) to "Buy"

July 14, 2025 | americanbankingnews.com

Axxcess Wealth Management LLC Acquires 1,557 Shares of TE Connectivity Ltd. (NYSE:TEL)

July 13, 2025 | marketbeat.com

TE Connectivity (NYSE:TEL) Price Target Raised to $190.00 at Bank of America

July 13, 2025 | americanbankingnews.com

Citigroup Upgrades TE Connectivity (NYSE:TEL) to "Buy"

July 13, 2025 | americanbankingnews.com

Wall Street Zen Upgrades TE Connectivity (NYSE:TEL) to Buy

July 12, 2025 | marketbeat.com

TE Connectivity (TEL) Receives a Buy from UBS

July 11, 2025 | theglobeandmail.com

Citigroup Upgrades TE Connectivity (TEL)

July 11, 2025 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
By Gabriel Osorio-Mazilli | June 23, 2025
View BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
Intel's Turnaround Strategy Shifts From Planning to Attack Mode
By Jeffrey Neal Johnson | June 20, 2025
View Intel's Turnaround Strategy Shifts From Planning to Attack Mode
3 AI Infrastructure Stocks With Strong Growth, Not Hype
By Chris Markoch | June 26, 2025
View 3 AI Infrastructure Stocks With Strong Growth, Not Hype
3 Reasons AMD Could Be the Hottest Stock of the Summer
By Sam Quirke | June 20, 2025
View 3 Reasons AMD Could Be the Hottest Stock of the Summer
Analysts Supercharge AMD Stock Ahead of Q2 AI Catalyst
By Thomas Hughes | June 26, 2025
View Analysts Supercharge AMD Stock Ahead of Q2 AI Catalyst

CRO, TEL, PTX, and SAN Company Descriptions

8970 (CRO.V) CVE:CRO

C$0.02 +0.01 (+50.00%)

As of 02/1/2018

Canadian Arrow Mines Limited is a mineral exploration and development company. The Company is engaged in the business of acquiring and exploring mineral properties in Ontario, Canada. The Company operates through Canadian exploration operations segment. It is focused on developing nickel-copper sulfide deposits. The Company holds interest in certain mining claims comprising leased mining and surface claims, and patented mining rights in the Porcupine Mining Division in the Province of Ontario. The Company's principal asset is the Kenbridge project, which includes a nickel-copper sulfide deposit containing over 44,000 tons of nickel. Kenbridge Nickel Project is located in Northwestern Ontario, Canada, and lies approximately 70 Kilometers southeast of the town of Kenora on over 80 patented and approximately three staked mineral claims. The Company's Alexo and Kelex deposits are located approximately 50 Kilometers east of Timmins, Ontario.

Pernix Therapeutics NASDAQ:PTX

Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription drugs primarily for the United States market. It targets underserved therapeutic areas, such as central nervous system (CNS), including pain, neurology, and psychiatry. The company's products comprise Zohydro ER with BeadTek, an opioid agonist indicated for the management of pain; Silenor, a non-narcotic, non-scheduled, and non-addictive prescription sleep aid for the treatment of insomnia characterized by difficulty with sleep maintenance; and Treximet, a fixed dose combination product indicated for the treatment of acute migraine. Pernix Therapeutics Holdings, Inc. markets and sells its non-core products, including generics through its wholly owned subsidiaries; and markets its non-promoted products through distributors and trade partners. It serves drug wholesalers, specialty pharmacies, retail drug stores, mass merchandisers, and grocery store pharmacies. Pernix Therapeutics Holdings, Inc. was founded in 1996 and is headquartered in Morristown, New Jersey.

Banco Santander NYSE:SAN

$8.42 -0.09 (-1.06%)

Closing price 03:59 PM Eastern

Extended Trading

$8.46 +0.04 (+0.43%)

As of 07:56 PM Eastern

Banco Santander, S.A. provides various financial services worldwide. The company operates through Retail Banking, Santander Corporate & Investment Banking, Wealth Management & Insurance, and PagoNxt segments. It offers demand and time deposits, mutual funds, and current and savings accounts; mortgages, consumer finance, loans, and various financing solutions; and project finance, debt capital markets, global transaction banking, and corporate finance services. The company also provides asset management and private banking services; and insurance products. In addition, it offers corporate and investment banking services; and digital payment solutions. Further, it offers online banking and financial services to retail, business, institutional, corporate, private banking and university customers and clients. The company was formerly known as Banco Santander Central Hispano SA and changed its name to Banco Santander, S.A. in February 2007. Banco Santander, S.A. was founded in 1856 and is headquartered in Madrid, Spain.

TE Connectivity NYSE:TEL

$179.03 +1.35 (+0.76%)

Closing price 03:59 PM Eastern

Extended Trading

$179.00 -0.03 (-0.02%)

As of 05:52 PM Eastern

TE Connectivity Ltd., together with its subsidiaries, manufactures and sells connectivity and sensor solutions in Europe, the Middle East, Africa, the AsiaPacific, and the Americas. The company operates through three segments: Transportation Solutions, Industrial Solutions, and Communications Solutions. The Transportation Solutions segment provides terminals and connector systems and components, sensors, relays, antennas, and application tooling products for use in the automotive, commercial transportation, and sensor markets. The Industrial Solutions segment offers terminals and connector systems and components; and interventional medical components, relays, heat shrink tubing, and wires and cables for industrial equipment, aerospace, defense, marine, medical, and energy markets. The Communications Solutions segment supplies electronic components, such as terminals and connector systems and components, relays, heat shrink tubing, and antennas for the data and devices, and appliances markets. The company sells its products to approximately 140 countries primarily through direct sales to manufacturers, as well as through third-party distributors. The company was formerly known as Tyco Electronics Ltd. and changed its name to TE Connectivity Ltd. in March 2011. TE Connectivity Ltd. was founded in 1941 and is based in Schaffhausen, Switzerland.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time